000 01423 a2200397 4500
005 20250513041943.0
264 0 _c19950608
008 199506s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0014-2999(94)00698-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchmidt, C J
245 0 0 _aThe selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cFeb 1995
300 _a273-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a3,4-Dihydroxyphenylacetic Acid
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aElectrophysiology
650 0 4 _aFluorobenzenes
_xpharmacology
650 0 4 _aHomovanillic Acid
_xmetabolism
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aMicrodialysis
650 0 4 _aPiperidines
_xpharmacology
650 0 4 _aPrefrontal Cortex
_xdrug effects
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRitanserin
_xpharmacology
650 0 4 _aSerotonin Antagonists
_xpharmacology
700 1 _aFadayel, G M
773 0 _tEuropean journal of pharmacology
_gvol. 273
_gno. 3
_gp. 273-9
856 4 0 _uhttps://doi.org/10.1016/0014-2999(94)00698-7
_zAvailable from publisher's website
999 _c7736702
_d7736702